These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 20819534

  • 1. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
    Peng S, Xiong LS, Xiao YL, Wang AJ, Lin JK, Hu PJ, Chen MH.
    Chin Med J (Engl); 2010 Aug 05; 123(15):2012-7. PubMed ID: 20819534
    [Abstract] [Full Text] [Related]

  • 2. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J, Du ZM, Chen MH, Lin JK, Hu PJ.
    Zhonghua Yi Xue Za Zhi; 2008 May 27; 88(20):1390-3. PubMed ID: 18953876
    [Abstract] [Full Text] [Related]

  • 3. Distension during gastroesophageal reflux: effects of acid inhibition and correlation with symptoms.
    Tipnis NA, Rhee PL, Mittal RK.
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug 27; 293(2):G469-74. PubMed ID: 17556589
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV, Viazis N, Vlachogiannakos J, Sgouros SN, Stefanidis G, Archimandritis A, Karamanolis DG.
    Am J Gastroenterol; 2010 Feb 27; 105(2):308-13. PubMed ID: 19809412
    [Abstract] [Full Text] [Related]

  • 5. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
    Bytzer P, Jones R, Vakil N, Junghard O, Lind T, Wernersson B, Dent J.
    Clin Gastroenterol Hepatol; 2012 Dec 27; 10(12):1360-6. PubMed ID: 22813439
    [Abstract] [Full Text] [Related]

  • 6. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
    Johnsson F, Hatlebakk JG, Klintenberg AC, Román J, Toth E, Stubberöd A, Falk A, Edin R.
    Scand J Gastroenterol; 2003 Apr 27; 38(4):354-9. PubMed ID: 12739706
    [Abstract] [Full Text] [Related]

  • 7. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
    Bajbouj M, Becker V, Phillip V, Wilhelm D, Schmid RM, Meining A.
    Digestion; 2009 Apr 27; 80(2):112-8. PubMed ID: 19641320
    [Abstract] [Full Text] [Related]

  • 8. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
    Wu JC, Lai LH, Chow DK, Wong GL, Sung JJ, Chan FK.
    Neurogastroenterol Motil; 2011 Feb 27; 23(2):155-60, e31. PubMed ID: 21087355
    [Abstract] [Full Text] [Related]

  • 9. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC, Weusten BL, Numans ME, de Wit NJ, Samsom M, Smout AJ.
    J Clin Gastroenterol; 2008 Feb 27; 42(5):441-7. PubMed ID: 18344896
    [Abstract] [Full Text] [Related]

  • 10. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF.
    Laryngoscope; 2005 Jul 27; 115(7):1230-8. PubMed ID: 15995512
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.
    Omari T, Davidson G, Bondarov P, Nauclér E, Nilsson C, Lundborg P.
    J Pediatr Gastroenterol Nutr; 2007 Nov 27; 45(5):530-7. PubMed ID: 18030229
    [Abstract] [Full Text] [Related]

  • 12. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
    Milkes D, Gerson LB, Triadafilopoulos G.
    Am J Gastroenterol; 2004 Jun 27; 99(6):991-6. PubMed ID: 15180715
    [Abstract] [Full Text] [Related]

  • 13. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE, Chehade R, Crowell MD.
    Am J Gastroenterol; 2011 Sep 27; 106(9):1604-11. PubMed ID: 21691342
    [Abstract] [Full Text] [Related]

  • 14. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC, Icaza ME, Vargas F, Valdovinos Díaz MA.
    Rev Gastroenterol Mex; 2003 Sep 27; 68(2):113-9. PubMed ID: 15127647
    [Abstract] [Full Text] [Related]

  • 15. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
    Ouatu-Lascar R, Triadafilopoulos G.
    Am J Gastroenterol; 1998 May 27; 93(5):711-6. PubMed ID: 9625114
    [Abstract] [Full Text] [Related]

  • 16. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.
    Am J Gastroenterol; 2008 Oct 27; 103(10):2446-53. PubMed ID: 18684197
    [Abstract] [Full Text] [Related]

  • 17. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
    Franke A, Hepp C, Harder H, Beglinger C, Singer MV.
    Scand J Gastroenterol; 2008 Oct 27; 43(12):1425-31. PubMed ID: 18924018
    [Abstract] [Full Text] [Related]

  • 18. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
    Ghoshal UC, Chourasia D, Tripathi S, Misra A, Singh K.
    Scand J Gastroenterol; 2008 Oct 27; 43(6):654-61. PubMed ID: 18569981
    [Abstract] [Full Text] [Related]

  • 19. GERD assessment including pH metry predicts a high response rate to PPI standard therapy.
    Kandulski A, Peitz U, Mönkemüller K, Neumann H, Weigt J, Malfertheiner P.
    BMC Gastroenterol; 2013 Jan 16; 13():12. PubMed ID: 23324360
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.